IOSP Innospec Inc

Price (delayed)

$93.63

Market cap

$2.32B

P/E Ratio

21.77

Dividend/share

$1.22

EPS

$4.3

Enterprise value

$2.26B

Innospec Inc. is an international specialty chemicals company with approximately 1900 employees in 24 countries. Innospec manufactures and supplies a wide range of specialty chemicals to markets in the Americas, ...

Highlights
IOSP's gross profit is up by 44% year-on-year and by 9% since the previous quarter
Innospec's revenue has increased by 39% YoY and by 9% QoQ
The debt rose by 19% since the previous quarter and by 14% year-on-year
The quick ratio is down by 5% YoY

Key stats

What are the main financial stats of IOSP
Market
Shares outstanding
24.82M
Market cap
$2.32B
Enterprise value
$2.26B
Valuations
Price to earnings (P/E)
21.77
Price to book (P/B)
2.17
Price to sales (P/S)
1.44
EV/EBIT
14.74
EV/EBITDA
11.52
EV/Sales
1.4
Earnings
Revenue
$1.62B
EBIT
$153.3M
EBITDA
$196.2M
Free cash flow
$7.2M
Per share
EPS
$4.3
Free cash flow per share
$0.29
Book value per share
$43.12
Revenue per share
$65.19
TBVPS
$48.76
Balance sheet
Total assets
$1.62B
Total liabilities
$554.9M
Debt
$42.4M
Equity
$1.07B
Working capital
$426.3M
Liquidity
Debt to equity
0.04
Current ratio
2.21
Quick ratio
1.26
Net debt/EBITDA
-0.32
Margins
EBITDA margin
12.1%
Gross margin
29.3%
Net margin
6.6%
Operating margin
9.1%
Efficiency
Return on assets
6.9%
Return on equity
10.4%
Return on invested capital
21.3%
Return on capital employed
12.1%
Return on sales
9.5%
Dividend
Dividend yield
1.3%
DPS
$1.22
Payout ratio
28.4%

IOSP stock price

How has the Innospec stock price performed over time
Intraday
2.6%
1 week
7.26%
1 month
-7.43%
1 year
-0.35%
YTD
3.64%
QTD
1.17%

Financial performance

How have Innospec's revenue and profit performed over time
Revenue
$1.62B
Gross profit
$473.4M
Operating income
$146.4M
Net income
$106.2M
Gross margin
29.3%
Net margin
6.6%
IOSP's gross profit is up by 44% year-on-year and by 9% since the previous quarter
Innospec's revenue has increased by 39% YoY and by 9% QoQ
Innospec's net income has increased by 14% from the previous quarter
The company's operating income rose by 12% QoQ

Growth

What is Innospec's growth rate over time

Valuation

What is Innospec stock price valuation
P/E
21.77
P/B
2.17
P/S
1.44
EV/EBIT
14.74
EV/EBITDA
11.52
EV/Sales
1.4
The stock's price to earnings (P/E) is 34% less than its 5-year quarterly average of 32.8 and 9% less than its last 4 quarters average of 23.9
The company's EPS rose by 14% QoQ
The equity is up by 11% YoY and by 3.5% from the previous quarter
Innospec's revenue has increased by 39% YoY and by 9% QoQ
The price to sales (P/S) is 4% lower than the last 4 quarters average of 1.5 but 2.9% higher than the 5-year quarterly average of 1.4

Efficiency

How efficient is Innospec business performance
Innospec's ROE has increased by 11% from the previous quarter
IOSP's ROA is up by 10% since the previous quarter
IOSP's return on invested capital is up by 7% since the previous quarter
The company's return on sales rose by 3.3% QoQ

Dividends

What is IOSP's dividend history
DPS
$1.22
Dividend yield
1.3%
Payout ratio
28.4%
Recent dividends

Financial health

How did Innospec financials performed over time
Innospec's total assets is 193% more than its total liabilities
The total liabilities has increased by 19% year-on-year and by 3.2% since the previous quarter
Innospec's total assets has increased by 14% YoY and by 3.4% from the previous quarter
The debt is 96% smaller than the equity
Innospec's debt to equity has increased by 33% from the previous quarter
The debt rose by 19% since the previous quarter and by 14% year-on-year

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.